GLYCOVAXYN

GlycoVaxyn AG, a vaccine biopharmaceutical company, develops and manufactures biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology. It develops and produces immunogenic glycoprotein conjugates vaccines for a range of bacterial diseases, such as pneumococcal and nosocomial infections.

#SimilarOrganizations #People #Financial #Website #More

GLYCOVAXYN

Social Links:

Linkedin

Industry:

Biotechnology Manufacturing Pharmaceutical

Founded:

2004-01-01

Address:

Schlieren, Zurich, Switzerland

Country:

Switzerland

Website Url:

http://www.glycovaxyn.com

Total Employee:

11+

Status:

Active

Contact:

+41447338585

Total Funding:

34.3 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Namecheap DNS Contabo

Similar Organizations

am-technology-logo

AM Technology

AM Technology designs and manufactures dynamically mixed continuous flow reactors.

Current Employees Featured

philippe-dro_image

Philippe Dro
Philippe Dro CEO & Board Member @ GlycoVaxyn
CEO & Board Member

Investors List

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Series B - GlycoVaxyn

edmond-de-rothschild-private-equity_image

Edmond de Rothschild Private Equity

Edmond de Rothschild Private Equity investment in Series B - GlycoVaxyn

index-ventures_image

Index Ventures

Index Ventures investment in Series B - GlycoVaxyn

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Series A - GlycoVaxyn

index-ventures_image

Index Ventures

Index Ventures investment in Series A - GlycoVaxyn

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Seed Round - GlycoVaxyn

index-ventures_image

Index Ventures

Index Ventures investment in Seed Round - GlycoVaxyn

Official Site Inspections

http://www.glycovaxyn.com

Host Informations
Whois Informations

Loading ...

More informations about "GlycoVaxyn" on Search Engine